Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Instagram Outage Disrupts Thousands of U.S. Users 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
MANHATTAN, N.Y., Sept. 12, 2017 -- Epica International, Inc., a leading robotic CT company based in San Clemente, California, recently announced the closing of a financing round with the investment group, Partners for Growth. PFG structured the $5 million term-debt facility in a key capital raise, providing growth capital to support Epica’s expansion into new markets across both imaging and robotics.
The NYC management consultancy, Facilitated Growth, acted as the key advisor on this deal, assisting in the rigorous diligence process for Epica’s five growing subsidiaries; a non-invasive CT medical imaging company, a robotics company, an advanced R&D technology center, a medical products distribution company, and a technical and scientific distribution group.
The funds are earmarked for use on growing operations, increasing the sales force, and preparing for entry into the human market. “This infusion of capital will assist us in furthering our goals to integrate CT imagery with precision robotics and ultimately deliver the future of medical diagnosis and therapy,” said Epica CEO, Frank D’Amelio.
Contact Info: Joe Soto, Facilitated Growth, [email protected], 212-697-1316
